{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:51:28Z","timestamp":1785887488965,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtha.2026.04.023","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:32:48Z","timestamp":1778196768000},"page":"2687-2698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Designing biomarker-selected international trials in sepsis-associated coagulopathy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.04.023_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_bib3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.04.023_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13613-024-01301-6","article-title":"Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines","volume":"14","author":"Iba","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40560-025-00776-0","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2024","volume":"13","author":"Shime","year":"2025","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.2011.09019.x","article-title":"The withdrawal of activated protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]","volume":"157","author":"Thachil","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.04.023_bib10","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.thromres.2011.08.028","article-title":"Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)","volume":"129","author":"Di Nisio","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.04.023_bib11","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","article-title":"The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation","volume":"11","author":"Iba","year":"2023","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/1076029616654263","article-title":"An evaluation of the modified diagnostic criteria for DIC established by the Japanese Society of Thrombosis and Hemostasis","volume":"23","author":"Aota","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/jcm15020488","article-title":"Recognizing coagulation disorders in sepsis in the emergency room: a narrative review","volume":"15","author":"Iba","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/jth.13948","article-title":"Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a \u2018pendulum effect\u2019 drug using a nationwide database","volume":"16","author":"Tagami","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12959-025-00788-8","article-title":"Association between recombinant human soluble thrombomodulin administration dosages and mortality in patients with sepsis-induced disseminated intravascular coagulation","volume":"23","author":"Kobayashi","year":"2025","journal-title":"Thromb J"},{"issue":"315","key":"10.1016\/j.jtha.2026.04.023_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"23","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.023_bib20","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_bib21","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13613-024-01380-5","article-title":"Sepsis-induced coagulopathy (SIC) in the management of sepsis","volume":"14","author":"Iba","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib23","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.3390\/jcm14124222","article-title":"Incidence of sepsis-induced coagulopathy (INSIC) trial: study protocol of a combined retrospective and prospective, multicenter, international, cross-sectional, longitudinal, and epidemiological observational trial","volume":"14","author":"Schmoch","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib25","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jtha.2025.03.038","article-title":"Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation","volume":"23","author":"Iba","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jtha.2022.10.022","article-title":"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis","volume":"21","author":"Iba","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2026.04.023_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-024-03896-9","article-title":"Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis","volume":"121","author":"Yamakawa","year":"2025","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2026.04.023_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_bib31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","article-title":"Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET","volume":"11","author":"Fran\u00e7ois","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/jth.12868","article-title":"Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality","volume":"13","author":"Levi","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109485","article-title":"Disseminated intravascular coagulation resolution as a surrogate outcome for mortality in sepsis-associated disseminated intravascular coagulation","volume":"255","author":"Wada","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.04.023_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12959-023-00556-6","article-title":"The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation","volume":"21","author":"Iba","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2026.04.023_bib36","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.023_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.243","article-title":"Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013","volume":"5","author":"Hayakawa","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.jtha.2026.04.023_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1751143714559903","article-title":"Peri-procedural management of bleeding risks in critical care patients: A local audit and national survey","volume":"16","author":"Hibbs","year":"2015","journal-title":"J Intensive Care Soc"},{"key":"10.1016\/j.jtha.2026.04.023_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26623-y","article-title":"Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence","volume":"12","author":"Zhou","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2026.04.023_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.04.023_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.14789\/jmj.JMJ24-0010-P","article-title":"Designing future clinical trials for sepsis-associated disseminated intravascular coagulation","volume":"70","author":"Maier","year":"2024","journal-title":"Juntendo Iji Zasshi"},{"key":"10.1016\/j.jtha.2026.04.023_bib42","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.04.023_sref43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cjtee.2023.04.006","article-title":"Why anticoagulant studies on sepsis fail frequently start with SCARLET","volume":"26","author":"Guo","year":"2023","journal-title":"Chin J Traumatol"},{"issue":"22","key":"10.1016\/j.jtha.2026.04.023_sref44","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2026.04.023_bib45","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/sim.9416","article-title":"Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation","volume":"41","author":"Schoenfeld","year":"2022","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib46","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1017\/cts.2024.492","article-title":"Trends in use of composite endpoints in clinical trials: A comparison between acute heart failure trials and COVID-19 trials","volume":"8","author":"Shi","year":"2024","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.jtha.2026.04.023_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154113","article-title":"Hierarchical endpoint analysis using win ratio in critical care: an exploration using the balanced solutions in intensive care study (BaSICS)","volume":"71","author":"Zampieri","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154767","volume":"82","author":"Zampieri","year":"2024","journal-title":"J Crit Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib49","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jtha.2026.04.023_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtha.2026.04.023_bib51","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.04.023_bib52","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3389\/fimmu.2019.02536","article-title":"DAMPs and NETs in Sepsis","volume":"10","author":"Denning","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.04.023_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/cc7130","article-title":"Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients","volume":"12","author":"K\u00fcmpers","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2026.04.023_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.jtha.2026.04.023_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtha.2026.04.023_bib56","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3389\/fimmu.2018.01502","article-title":"Arguing for adaptive clinical trials in Sepsis","volume":"9","author":"Talisa","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.04.023_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.04.023_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ams2.411","article-title":"Japanese Surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy","volume":"6","author":"Iba","year":"2019","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jtha.2026.04.023_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109554","article-title":"Thrombosis, bleeding, and mortality in patients with sepsis-induced coagulopathy: analysis of a prospective cohort","volume":"257","author":"Turcato","year":"2026","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.04.023_bib60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/life13020350","article-title":"Sepsis-induced coagulopathy: an update on pathophysiology, biomarkers, and current guidelines","volume":"13","author":"Tsantes","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.jtha.2026.04.023_bib61","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3904\/kjim.2017.034","article-title":"Harmonization of laboratory results by data adjustment in multicenter clinical trials","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jtha.2026.04.023_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/advances\/nmaa088","article-title":"Perspective: laboratory considerations and clinical data management for human nutrition randomized controlled trials: guidance for ensuring quality and integrity","volume":"12","author":"Maki","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jtha.2026.04.023_bib63","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.124.070251","article-title":"Hierarchical composite outcomes and win ratio methods in cardiovascular trials: a review and consequent guidance","volume":"151","author":"Gregson","year":"2025","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:22:55Z","timestamp":1785885775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626002734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1538783626002734"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing biomarker-selected international trials in sepsis-associated coagulopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}